PMEL and melanoma: Adoptive transfer of pmel TCR-transgenic T cells that recognize the melanoma antigen gp100 into tumor-bearing mice just prior to therapy revealed that AIP induced antigen presentation and activation of tumor-specific T cells in TDLNs by 1 day following treatment (Figures 2H–2J).